Drug name - Axiron

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8784878 ELI LILLY AND CO Transdermal delivery rate control using amorphous pharmaceutical compositions Jul, 2023

(9 months from now)

US8993520 ELI LILLY AND CO Method and composition for transdermal drug delivery Jun, 2026

(3 years from now)

US9180194 ELI LILLY AND CO Method and composition for transdermal drug delivery Jun, 2026

(3 years from now)

US8807861 ELI LILLY AND CO Spreading implement Feb, 2027

(4 years from now)

US8419307 ELI LILLY AND CO Spreading implement Feb, 2027

(4 years from now)

US9289586 ELI LILLY AND CO Spreading implement Feb, 2027

(4 years from now)

US8435944 ELI LILLY AND CO Method and composition for transdermal drug delivery Sep, 2027

(4 years from now)

Drugs and Companies using TESTOSTERONE ingredient

Treatment: A method of transdermally delivering testosterone; A method of increasing the testosterone blood level of an adult male subject in need thereof; A method of transdermal administration of a physiologically active agent to a subject.; A method of increasing the testosterone blood level of a person in need thereof

Dosage: SOLUTION, METERED;TRANSDERMAL

More Information on Dosage
Strength Dosage Availability
30MG/1.5ML ACTUATION SOLUTION, METERED;TRANSDERMAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.